Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study of the Pharmacokinetics of Melphalan During Treatment With Melflufen and Dexamethasone in Patients With Relapsed Refractory Multiple Myeloma and Impaired Renal Function

NCT03639610 is registered in ClinicalTrials.gov with Oncopeptides AB as lead sponsor.

NCT NCT03639610
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03639610 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study of the Pharmacokinetics of Melphalan During Treatment With Melflufen and Dexamethasone in Patients With Relapsed Refractory Multiple Myeloma and Impaired Renal Function
Lead sponsor
Oncopeptides AB
Phase
Phase 2
Overall status
Terminated
Start date
August 28, 2018
Completion date
December 22, 2021
Enrollment
35 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

multiple myeloma, renal impairment